FDA Pilot Program Eases Rules for Nicotine Pouch Makers 
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
Nintendo Shares Jump as Switch 2 Sales Boost Earnings 
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission 
S&P 500, Nasdaq Slip as Oil Jumps on Iran Tensions 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
England Drought Expands to 71% as Heatwave Deepens Water Crisis 
Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results 
Blue Origin New Glenn Explosion Could Delay Launch Operations Until 2028 
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback 
Asian Currencies Steady as Markets Await U.S. Inflation Data 
UK Retail Sales Rise as World Cup and Heatwave Boost Food, Pubs and Clothing 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
Czech-based Mewery has introduced a prototype of microalgae-based cultivated meat, combining 75 percent pork cells and 25 percent microalgae cells.
The scientific team of Mewery, a cell-based food tech start-up, , cultivated this prototype in 10 weeks.
According to Mewery founder, Roman Lauš, they already have several variants that work for them without animal products and which they continue to work with.
The addition of microalgae improves the product's nutritional value by providing vitamins, antioxidants, minerals, fiber, and vital fatty acids.
Mewery hopes to have the finished product available for sale in two years. Once the necessary legislation is ready, consumers will have access to it.
